AIxCrypto Holdings (AIXC)
NASDAQ:AIXC
AIXC Stock Chart & Stats
$2.65
--
Market closed
$2.65
--
Day’s Range― - ―
52-Week Range$0.92 - $8.81
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.38M
Market Cap
$7.02M
Enterprise Value-$28.73M
Total Cash (Recent Filing)$38.78M
Total Debt (Recent Filing)$3.24M
Price to Earnings (P/E)―
Beta1.87
Next Earnings
May 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,160,382
10 Day Avg. Volume295,576
30 Day Avg. Volume2,383,814
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.57
Price to Sales (P/S)0.00
P/FCF Ratio-0.24
Enterprise Value/Market Cap-4.09
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit272.11
Enterprise Value/Ebitda4.43
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AIxCrypto Holdings News
AIXC FAQ
What was AIxCrypto Holdings’s price range in the past 12 months?
AIxCrypto Holdings lowest stock price was $0.92 and its highest was $8.81 in the past 12 months.
What is AIxCrypto Holdings’s market cap?
AIxCrypto Holdings’s market cap is $7.02M.
When is AIxCrypto Holdings’s upcoming earnings report date?
AIxCrypto Holdings’s upcoming earnings report date is May 08, 2026 which is in 43 days.
How were AIxCrypto Holdings’s earnings last quarter?
Currently, no data Available
Is AIxCrypto Holdings overvalued?
According to Wall Street analysts AIxCrypto Holdings’s price is currently Overvalued.
Does AIxCrypto Holdings pay dividends?
AIxCrypto Holdings does not currently pay dividends.
What is AIxCrypto Holdings’s EPS estimate?
AIxCrypto Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AIxCrypto Holdings have?
AIxCrypto Holdings has 5,160,382 shares outstanding.
What happened to AIxCrypto Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AIxCrypto Holdings?
Currently, no hedge funds are holding shares in AIXC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AIxCrypto Holdings
AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. The company was founded in 1996 and is based in Carlsbad, California.
Ownership Overview
―
Insiders
0.11%
Mutual Funds
<0.01% Other Institutional Investors
99.88% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---